ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00996762
Recruitment Status : Completed
First Posted : October 16, 2009
Last Update Posted : November 13, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 18, 2012
  Actual Study Completion Date : September 18, 2012